Mink Therapeutics (INKT) Stock Performance
- Price movement: Mink Therapeutics shares increased by 1.59 % during the 24‑hour period ending at 08:22 AM Central European Time on Wednesday, 21 April 2026.
- Current price: The stock trades at USD 9.86 on major exchanges.
- Shares outstanding: 5.1 million shares.
- Market capitalization: USD 49.4 million.
- Recent trading volume: Approximately USD 134.8 k of shares were traded in the last 24 hours.
- Performance since last month‑end: The share price has declined by 21.96 %.
- Moving average: The simple moving average of the last 200 trading days is USD 11.36.
- 52‑week range: The highest price reached USD 16.93 on 03 October 2026; the lowest price was USD 8.48 on 24 March 2026.
Comparison with Peer Stocks (Last 24 Hours)
| Ticker | Price Change | Current Price | Market Capitalisation | P/E Ratio (if available) |
|---|---|---|---|---|
| ADBT (Advasa) | 0 % | USD 0.11 | USD 57.5 million | 115.46 |
| VOC (Voc Energy) | +0.29 % | USD 3.40 | USD 57.6 million | 8.36 |
| MCHX (Marchex) | 0 % | USD 1.28 | USD 57.1 million | – |
| SAFX (Xcf Global) | +12.14 % | USD 0.21 | USD 58.3 million | – |
| DXR (Daxor) | –2.09 % | USD 9.75 | USD 58.7 million | 9.42 |
Company Overview
Mink Therapeutics, Inc. is a U.S.-based clinical‑stage biopharmaceutical company headquartered in New York. The company focuses on the discovery, development, and commercialization of allogeneic, off‑the‑shelf, invariant natural killer T (iNKT) cell therapies aimed at treating cancer and immune‑mediated diseases. Mink Therapeutics is listed on the Nasdaq stock exchange. For more information, visit the company’s website at www.minktherapeutics.com .
